Improving predictability and transparency in DEA and FDA regulation : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 7, 2014.
| Author/creator | United States |
| Format | Electronic |
| Publication | Washington : U.S. Government Publishing Office, 2015. |
| Description | 1 online resource (iv, 217 pages) |
| Supplemental Content | https://purl.fdlp.gov/GPO/gpo59306 |
| Subjects |
| General note | Title from title screen (viewed on July 24, 2015). |
| General note | Paper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office. |
| General note | "Serial No. 113-147." |
| General note | GPO Cataloging Record Distribution Program (CRDP). |
| Bibliography note | Includes bibliographical references. |
| Issued in other form | Print version: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. Improving predictability and transparency in DEA and FDA regulation |
| Issued in other form | Microfiche version: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. Improving predictability and transparency in DEA and FDA regulation |
| Genre/form | Legislative hearings. |
| Technical rpt number | Serial no. 113-137 (United States. Congress. House. Committee on Energy and Commerce) |
| GPO item number | 1019-C-01 (online) |
| Govt. docs number | Y 4.C 73/8:113-137 |